Plant-Derived Extracellular Vesicles in Cancer Therapeutics and Drug Delivery
A special issue of Pharmaceutics (ISSN 1999-4923). This special issue belongs to the section "Drug Delivery and Controlled Release".
Deadline for manuscript submissions: 20 March 2025 | Viewed by 24
Special Issue Editors
Interests: photothermal therapy; photodynamic therapy; 3D bioprinting; cancer; extracellular vesicles
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
Plant-derived extracellular vesicles (PDEVs) offer a novel and biocompatible approach for cancer therapy, functioning as naturally occurring nanoparticles that deliver therapeutic molecules directly to cancer cells. Their natural composition reduces off-target effects and enhances patient outcomes, making them a promising tool in oncology. This Special Issue will focus on the latest advancements in PDEVs, highlighting their natural advantages, tumor-targeting capabilities, and innovative applications in cancer therapeutics.
This Special Issue seeks to gather research and reviews that emphasize the natural properties, mechanisms of action, and clinical relevance of PDEVs in cancer therapy. The goal is to compile a comprehensive collection of articles that showcase the unique potential of PDEVs.
The suggested themes for this Special Issue will include the following:
- Biocompatibility and safety of PDEVs;
- Tumor-targeting mechanisms;
- Engineering and characterization;
- Comparative analysis with synthetic nanoparticles;
- Preclinical/clinical efficacy.
We look forward to receiving your contributions.
Dr. Giordano Perini
Dr. Lishan Cui
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Pharmaceutics is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- plant-derived extracellular vesicles
- cancer therapeutics
- drug delivery systems
- nanoparticles
- oncology
- molecular mechanisms
- targeted therapy
- biocompatibility
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Further information on MDPI's Special Issue polices can be found here.
